Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Chemokines in immunity.

O Yoshie1, T Imai, H Nomiyama

  • 1Department of Microbiology, Kinki University School of Medicine, Osaka-Sayama, Osaka 589-8511, Japan. o.yoshie@med.kindai.ac.jp

Advances in Immunology
|July 4, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Selective down-regulation of Th2 cell-mediated airway inflammation in mice by pharmacological intervention of CCR4.

Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology·2011
Same author

MRP-1/CD9 and KAI1/CD82 expression in normal and various cancer tissues.

International journal of oncology·2011
Same author

Abundant expression of CXCL9 (MIG) by stromal cells that include dendritic cells and accumulation of CXCR3+ T cells in lymphocyte-rich gastric carcinoma.

The Journal of pathology·2008
Same author

Aberrant expression of Fra-2 promotes CCR4 expression and cell proliferation in adult T-cell leukemia.

Oncogene·2007
Same author

Therapeutic effect of CXCR3-expressing regulatory T cells on liver, lung and intestinal damages in a murine acute GVHD model.

Gene therapy·2007
Same author

Accumulation of plasma cells expressing CXCR3 in the synovial sublining regions of early rheumatoid arthritis in association with production of Mig/CXCL9 by synovial fibroblasts.

Clinical and experimental immunology·2005
Same journal

The roles and diversity of alarmins in the mucosae.

Advances in immunology·2026
Same journal

Principles of resident tissue macrophages revealed by the eye.

Advances in immunology·2026
Same journal

Beyond suppression: Treg specialization in infection and tissue repair.

Advances in immunology·2026
Same journal

Ontogeny and function of microglia and nerve-associated macrophages.

Advances in immunology·2025
Same journal

Neuroimmunology beyond the CNS: Nerve-macrophage interactions in peripheral tissues.

Advances in immunology·2025
Same journal

Modulation of humoral immunity by γδ T cells: A potential adjuvant strategy for vaccination.

Advances in immunology·2025
See all related articles

Chemokines, crucial for immune cell movement, are now understood to include "immune chemokines" distinct from inflammatory types. These new chemokines regulate lymphocyte and dendritic cell traffic, offering therapeutic potential.

Area of Science:

  • Immunology
  • Molecular Biology
  • Cell Biology

Background:

  • Chemokines are cytokines that guide leukocyte migration via G protein-coupled receptors.
  • Traditionally viewed as mediators of inflammation, over 40 human chemokines were known.
  • Classical chemokines exhibit complex ligand-receptor interactions and specific gene locations.

Purpose of the Study:

  • To characterize newly identified chemokines.
  • To differentiate novel chemokines from classical inflammatory types.
  • To explore the role of these chemokines in immune system regulation.

Main Methods:

  • Bioinformatic analysis of expressed sequence tag databases.
  • Identification and characterization of novel chemokine sequences.

Related Experiment Videos

  • Gene mapping and expression pattern analysis.

    • Main Results:

    • Discovery of novel chemokines with distinct functional and genetic profiles.
    • Identification of constitutively expressed chemokines with specific patterns in lymphoid tissues.
    • Demonstration of simpler ligand-receptor relationships for new chemokines, often specific to lymphocytes and dendritic cells.

    Conclusions:

    • Emerging chemokines, termed "immune chemokines," differ significantly from classical "inflammatory chemokines."
    • Immune chemokines are vital for immune system development, maintenance, and function.
    • Immune chemokines and their receptors represent promising targets for immunomodulatory therapies.